ERDERA will launch its Clinical Trial Call 2026 (ECTC)on 1 July 2026, which will support multinational, GCP‑compliant early‑phase interventional clinical trials in the field of rare diseases. This call represents a key opportunity to advance collaborative research efforts and accelerate the development of innovative therapeutic approaches for patients affected by rare conditions.
To provide further information and guidance on the call, ERDERA will host an informational webinar on 6 July 2026, from 15:00 to 17:00. During this session, participants will have the opportunity to hear directly from ERDERA experts, who will present the objectives, scope, and requirements of the call, and address questions from prospective applicants.